Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

First report of CTX-M-extended-spectrum beta-lactamase- producing isolates from Croatia (CROSBI ID 125108)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Tonkić, Marija ; Bedenić, Branka ; Goić-Barišić, Ivana ; Katić, Stjepan ; Kalenić, Smilja ; Kaufmann, Mary ; Woodford, Neil ; Punda-Polić, Volga First report of CTX-M-extended-spectrum beta-lactamase- producing isolates from Croatia // Journal of chemotherapy, 19 (2007), 1; 97-100

Podaci o odgovornosti

Tonkić, Marija ; Bedenić, Branka ; Goić-Barišić, Ivana ; Katić, Stjepan ; Kalenić, Smilja ; Kaufmann, Mary ; Woodford, Neil ; Punda-Polić, Volga

engleski

First report of CTX-M-extended-spectrum beta-lactamase- producing isolates from Croatia

Five clinical Escherichia coli isolates from University Hospital Split, Croatia, with a CTX-M resistance phenotype (high level of resistance to cefotaxime and ceftriaxone) were screened for blaCTX-M alleles by PCR and confirmed to produce a group 1 CTX-M enzyme. ESBL phenotype was transferred by conjugation from 3 isolates to a rifampicin-resistant recipient strain. PFGE proved that two of these five strains were clonally related. This is the first report from Croatia of CTX-M type enzyme. Carbapenems could be recommended as antibiotics of choice for the treatment of infections caused by our CTX-M producing E. coli isolates.

extended-spectrum beta-lactamases; CTX-M-beta-lactamases; Escherichia coli; cefotaxime

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

19 (1)

2007.

97-100

objavljeno

1120-009X

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost